| Gene symbol | CTAG1B | Synonyms | CTAG, ESO1, CT6.1, CTAG1, LAGE-2, LAGE2B, NY-ESO-1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | cancer/testis antigen 1B | ||||
| GTO ID | GTC1399 |
| Trial ID | NCT01457131 |
| Disease | Metastatic Melanoma | Renal Cell Cancer |
| Altered gene | NY-ESO-1 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | NY-ESO-1 TCR-T cells |
| HLA | HLA-A*02:01 |
| Phase | Phase1 |
| Recruitment status | Terminated |
| Title | Phase I/II Study of Metastatic Cancer That Expresses NY-ESO-1 Using Lymphodepleting Conditioning Followed by Infusion of Gene Engineered Lymphocytes Cotransduced With Genes Encoding IL-12 and Anti-NY ESO-1 TCR |
| Year | 2011 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 120006|12-C-0006 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||